624 related articles for article (PubMed ID: 26025724)
21. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.
Groeneweg JA; Bhonsale A; James CA; te Riele AS; Dooijes D; Tichnell C; Murray B; Wiesfeld AC; Sawant AC; Kassamali B; Atsma DE; Volders PG; de Groot NM; de Boer K; Zimmerman SL; Kamel IR; van der Heijden JF; Russell SD; Jan Cramer M; Tedford RJ; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Hauer RN; Calkins H
Circ Cardiovasc Genet; 2015 Jun; 8(3):437-46. PubMed ID: 25820315
[TBL] [Abstract][Full Text] [Related]
22. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia.
Yoerger DM; Marcus F; Sherrill D; Calkins H; Towbin JA; Zareba W; Picard MH;
J Am Coll Cardiol; 2005 Mar; 45(6):860-5. PubMed ID: 15766820
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Aquaro GD; De Luca A; Cappelletto C; Raimondi F; Bianco F; Botto N; Lesizza P; Grigoratos C; Minati M; Dell'Omodarme M; Pingitore A; Stolfo D; Ferro MD; Merlo M; Di Bella G; Sinagra G
J Am Coll Cardiol; 2020 Jun; 75(22):2753-2765. PubMed ID: 32498802
[TBL] [Abstract][Full Text] [Related]
24. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
te Riele AS; Bhonsale A; James CA; Rastegar N; Murray B; Burt JR; Tichnell C; Madhavan S; Judge DP; Bluemke DA; Zimmerman SL; Kamel IR; Calkins H; Tandri H
J Am Coll Cardiol; 2013 Nov; 62(19):1761-9. PubMed ID: 23810894
[TBL] [Abstract][Full Text] [Related]
25. Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia.
Chimenti C; Pieroni M; Maseri A; Frustaci A
J Am Coll Cardiol; 2004 Jun; 43(12):2305-13. PubMed ID: 15193698
[TBL] [Abstract][Full Text] [Related]
26. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
27. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Value of Right Ventricular Deformation Imaging in Early Arrhythmogenic Right Ventricular Cardiomyopathy.
Mast TP; Taha K; Cramer MJ; Lumens J; van der Heijden JF; Bouma BJ; van den Berg MP; Asselbergs FW; Doevendans PA; Teske AJ
JACC Cardiovasc Imaging; 2019 Mar; 12(3):446-455. PubMed ID: 29550307
[TBL] [Abstract][Full Text] [Related]
29. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.
Lemola K; Brunckhorst C; Helfenstein U; Oechslin E; Jenni R; Duru F
Heart; 2005 Sep; 91(9):1167-72. PubMed ID: 16103549
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic arrhythmogenic right ventricular dysplasia/cardiomyopathy. A two-centre retrospective study of 15 symptomatic ARVD/C cases and focus on the diagnostic value of MRI in symptomatic ARVD/C patients.
Dewilde W; Boersma L; Delanote J; Pollet P; Scholzel B; Wever E; Vandekerckhove Y
Acta Cardiol; 2008 Apr; 63(2):181-9. PubMed ID: 18468198
[TBL] [Abstract][Full Text] [Related]
31. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
Sen-Chowdhry S; Syrris P; Ward D; Asimaki A; Sevdalis E; McKenna WJ
Circulation; 2007 Apr; 115(13):1710-20. PubMed ID: 17372169
[TBL] [Abstract][Full Text] [Related]
32. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot.
Diller GP; Kempny A; Liodakis E; Alonso-Gonzalez R; Inuzuka R; Uebing A; Orwat S; Dimopoulos K; Swan L; Li W; Gatzoulis MA; Baumgartner H
Circulation; 2012 May; 125(20):2440-6. PubMed ID: 22496160
[TBL] [Abstract][Full Text] [Related]
33. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.
Cox MG; van der Zwaag PA; van der Werf C; van der Smagt JJ; Noorman M; Bhuiyan ZA; Wiesfeld AC; Volders PG; van Langen IM; Atsma DE; Dooijes D; van den Wijngaard A; Houweling AC; Jongbloed JD; Jordaens L; Cramer MJ; Doevendans PA; de Bakker JM; Wilde AA; van Tintelen JP; Hauer RN
Circulation; 2011 Jun; 123(23):2690-700. PubMed ID: 21606396
[TBL] [Abstract][Full Text] [Related]
34. Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Wlodarska EK; Wozniak O; Konka M; Rydlewska-Sadowska W; Biederman A; Hoffman P
Europace; 2006 Aug; 8(8):596-600. PubMed ID: 16760233
[TBL] [Abstract][Full Text] [Related]
35. Utility of strain echocardiography at rest and after stress testing in arrhythmogenic right ventricular dysplasia.
Vitarelli A; Cortes Morichetti M; Capotosto L; De Cicco V; Ricci S; Caranci F; Vitarelli M
Am J Cardiol; 2013 May; 111(9):1344-50. PubMed ID: 23411103
[TBL] [Abstract][Full Text] [Related]
36. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
te Riele AS; James CA; Groeneweg JA; Sawant AC; Kammers K; Murray B; Tichnell C; van der Heijden JF; Judge DP; Dooijes D; van Tintelen JP; Hauer RN; Calkins H; Tandri H
Eur Heart J; 2016 Mar; 37(9):755-63. PubMed ID: 26314686
[TBL] [Abstract][Full Text] [Related]
37. Early Left Ventricular Involvement Detected by Cardiovascular Magnetic Resonance Feature Tracking in Arrhythmogenic Right Ventricular Cardiomyopathy: The Effects of Left Ventricular Late Gadolinium Enhancement and Right Ventricular Dysfunction.
Chen X; Li L; Cheng H; Song Y; Ji K; Chen L; Han T; Lu M; Zhao S
J Am Heart Assoc; 2019 Sep; 8(17):e012989. PubMed ID: 31441357
[TBL] [Abstract][Full Text] [Related]
38. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.
Berte B; Denis A; Amraoui S; Yamashita S; Komatsu Y; Pillois X; Sacher F; Mahida S; Wielandts JY; Sellal JM; Frontera A; Al Jefairi N; Derval N; Montaudon M; Laurent F; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1403-12. PubMed ID: 26311712
[TBL] [Abstract][Full Text] [Related]
40. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
